"Early-peak" carbon monoxide production in certain erythropoietic disorders.
The "early-labeled" peak (ELP) of 14CO excretion following injection of glycine-2-14C was used to study erythropoiesis in a patient with sideroblastic anemia and in four subjects with myeloproliferative disorders. The ELP was greatly enlarged in all patients, as compared with a normal volunteer. The contour of the peaks from the hematologically abnormal subjects suggested the presence of increased erythroid heme degradation. In the patient with sideroblastic anemia, all hours of the early peak were significantly reduced after transfusion. This was interpreted to mean that even the earliest or "nonerythroid" phase of the peak is influenced by erythropoietic activity, at least under conditions of erythropoietic stress.
D000756:Anemia, Sideroblastic / Q000378:metabolism*; D001792:Blood Platelets; D001803:Blood Transfusion; D001944:Breath Tests; D002245:Carbon Dioxide / Q000032:analysis; D002248:Carbon Monoxide / Q000096:biosynthesis*; D002250:Carbon Radioisotopes; D002470:Cell Survival; D002860:Chromium Radioisotopes; D004912:Erythrocytes; D004920:Erythropoiesis; D005998:Glycine / Q000378:metabolism; D006418:Heme / Q000378:metabolism; D007958:Leukocyte Count; D009196:Myeloproliferative Disorders / Q000378:metabolism*; D013997:Time Factors
D002250:Carbon Radioisotopes; D002860:Chromium Radioisotopes; D002245:Carbon Dioxide; D006418:Heme; D002248:Carbon Monoxide; D005998:Glycine